NovaBay Accounts Payable from 2010 to 2024

NBY Stock  USD 0.61  0.01  1.61%   
NovaBay Pharmaceuticals Accounts Payable yearly trend continues to be fairly stable with very little volatility. Accounts Payable will likely drop to about 812.7 K in 2024. Accounts Payable is the amount NovaBay Pharmaceuticals owes to suppliers or vendors for products or services received but not yet paid for. It represents NovaBay Pharmaceuticals' short-term liabilities. View All Fundamentals
 
Accounts Payable  
First Reported
2005-12-31
Previous Quarter
1.2 M
Current Value
396 K
Quarterly Volatility
566 K
 
Housing Crash
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check NovaBay Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among NovaBay Pharmaceuticals' main balance sheet or income statement drivers, such as Depreciation And Amortization of 229.5 K, Interest Expense of 4.6 M or Other Operating Expenses of 16.9 M, as well as many indicators such as Price To Sales Ratio of 0.0555, Dividend Yield of 0.0 or PTB Ratio of 0.25. NovaBay financial statements analysis is a perfect complement when working with NovaBay Pharmaceuticals Valuation or Volatility modules.
  
Check out the analysis of NovaBay Pharmaceuticals Correlation against competitors.
For more information on how to buy NovaBay Stock please use our How to Invest in NovaBay Pharmaceuticals guide.

Latest NovaBay Pharmaceuticals' Accounts Payable Growth Pattern

Below is the plot of the Accounts Payable of NovaBay Pharmaceuticals over the last few years. An accounting item on the balance sheet that represents NovaBay Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of NovaBay Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. NovaBay Pharmaceuticals' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in NovaBay Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable10 Years Trend
Very volatile
   Accounts Payable   
       Timeline  

NovaBay Accounts Payable Regression Statistics

Arithmetic Mean883,911
Geometric Mean675,150
Coefficient Of Variation75.89
Mean Deviation529,804
Median551,000
Standard Deviation670,777
Sample Variance449.9B
Range2.3M
R-Value0.01
Mean Square Error484.5B
R-Squared0.000086
Significance0.97
Slope1,392
Total Sum of Squares6.3T

NovaBay Accounts Payable History

2024812.7 K
20231.1 M
20221.1 M
2021M
2020302 K
2019331 K
2018551 K

About NovaBay Pharmaceuticals Financial Statements

NovaBay Pharmaceuticals investors use historical fundamental indicators, such as NovaBay Pharmaceuticals' Accounts Payable, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in NovaBay Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Accounts Payable1.1 M812.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for NovaBay Stock Analysis

When running NovaBay Pharmaceuticals' price analysis, check to measure NovaBay Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovaBay Pharmaceuticals is operating at the current time. Most of NovaBay Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of NovaBay Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovaBay Pharmaceuticals' price. Additionally, you may evaluate how the addition of NovaBay Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.